Array
(
[id] => 13926083
[patent_doc_number] => 20190046557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-14
[patent_title] => CANCER TREATMENT USING BETA-(1-3)-(1-4)-GLUCAN
[patent_app_type] => utility
[patent_app_number] => 16/059511
[patent_app_country] => US
[patent_app_date] => 2018-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11189
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16059511
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/059511 | Cancer treatment using beta-(1-3)-(1-4)-glucan | Aug 8, 2018 | Issued |